Email
Print
Mefloquine Market Overview
Global Mefloquine Market size is estimated to reach $412.3 million by 2027, growing at a CAGR of 4.1% during the forecast period 2022-2027. Mefloquine is an antiparasitic medication, utilized for the treatment of malaria. Mefloquine brand name includes Lariam with the Drug class(es): antimalarial quinolines classified under mefloquine systemic. Mefloquine storage involves storing the medication in a closed container at room temperature, away from heat, moisture and direct light. The usual Mefloquine Dose for malaria pertaining to adults involves 1250 mg orally as a single dose. Typical mefloquine side effects include abdominal pain, abnormal dreams and anxiety among others. The surging application of the recommended Mefloquine Dose to avoid and treat malaria is set to drive the Global Mefloquine Market. The effectiveness of Mefloquine against malaria parasites resistant to chloroquine is set to propel the growth of the Global Mefloquine Industry during the forecast period 2022-2027. This represents the Global Mefloquine Industry Outlook.
Mefloquine Market Report Coverage
The “Global Mefloquine Market Report - Forecast (2022-2027)” by Industry ARC, covers an in-depth analysis of the following segments in the Global Mefloquine Market.
by Type: Purity 98%, Purity 99% and Others.
by End-use Industry: Chemical Industry and Pharmaceutical Industry.
by Geography: North America (the U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and the Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and the Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest Of The World (the Middle East and Africa).
Key Takeaways
- Geographically, North America (Global Mefloquine market share) accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the existence of key players like Toronto Research Chemicals and the application of the recommended Mefloquine Dose to treat malaria in the North American region.
- Global Mefloquine Market growth is being driven by the increasing predominance of malaria in regions like Africa and the application of medication with the mefloquine brand name. However, certain people consuming mefloquine have had sudden severe psychiatric or nerve issues, with mefloquine side effects being permanent and this is one of the major factors hampering the growth of the Global Mefloquine Market.
- Global Mefloquine Market Detailed Analysis of the Strengths, Weaknesses and Opportunities of the prominent players operating in the market will be provided in the Global Mefloquine Market report.
Mefloquine Market: Market Share (%) by Region, 2021
For More Details on This Report - Request for Sample
Mefloquine Market Segment Analysis - by Type
The Global Mefloquine Market based on type can be further segmented into Purity 98%, Purity 99% and Others. The Purity 99% Segment held the largest Global Mefloquine market share in 2021. This growth is owing to the surging application of high purity 99% mefloquine to treat malaria. Mefloquine HCl is a blood schizonticide by restricting hemozoin formation and is utilized as an antimalarial medication. The surging availability of Mefloquine hydrochloride 99% (HPLC) online is further propelling the growth of the Purity 99% segment.
Furthermore, the Purity 98% segment is estimated to grow with the fastest CAGR of 5.6% during the forecast period 2022-2027 owing to the soaring availability of Mefloquine hydrochloride 98% (HPLC), powder to treat cochlear organotypic cultures with different doses to assess its role in cellular pathway included in apoptosis and with Mefloquine storage conditions followed.
Mefloquine Market Segment Analysis - by End-use Industry
The Global Mefloquine Market based on end-use industry can be further segmented into Chemical Industry and Pharmaceutical Industry. The Pharmaceutical Industry Segment held the largest Global Mefloquine market share in 2021. This growth is owing to the surging application of Mefloquine as an antiparasitic medication to treat malaria. Mefloquine storage conditions need to be followed. The capability of Mefloquine to destroy the malaria-causing parasite and to halt the infection from spreading are further propelling the growth of this segment.
Furthermore, the Pharmaceutical Industry segment is estimated to grow with the fastest CAGR of 5.9% during the forecast period 2022-2027 owing to the soaring application of Mefloquine as the principal antimalarial medication by the Brazilian government and as an active pharmaceutical ingredient (API) together with the Mefloquine storage conditions being followed.
Mefloquine Market Segment Analysis - by Geography
The Global Mefloquine Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America and Rest of the World. North America (Global Mefloquine Market) held the largest Global Mefloquine market share with 31% of the overall market in 2021. The growth of this region is owing to the increasing predominance of malaria in recent years in the U.S. in the North American region. The rising international travel strongly leading to malaria being a cause of fever is further propelling the growth of the Global Mefloquine Industry, thereby contributing to the growth of the Global Mefloquine Industry Outlook, in the North American region.
Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR over the forecast period 2022-2027. This growth is owing to factors like the increasing application of Mefloquine to treat malaria in the Asia-Pacific region. The intake of Mefloquine once weekly to prevent malaria is further fuelling the progress of the Global Mefloquine Market in the Asia-Pacific region.
Mefloquine Market Drivers
Surging Applications of Mefloquine are Projected to Drive the Growth of the Mefloquine Market:
Mefloquine dose includes one 250mg Mefloquine hydrochloride tablet to be consumed once weekly. Mefloquine's brand name includes Lariam. Mefloquine is a medication utilized to treat malaria. Malaria is an ailment brought about by parasites. Mefloquine performs by intervening with the development of parasites in the red blood cells of the human body. Parasites that bring about malaria typically enter the body by way of the bite of a mosquito. Malaria is typical in areas like Africa, South America and Southern Asia. Mefloquine is also utilized to avert malaria. The surging applications of Mefloquine are therefore fuelling the growth of the Global Mefloquine Market during the forecast period 2022-2027.
Increasing Predominance of Malaria is Expected to Boost the Growth of the Mefloquine Industry:
As per World Health Organization (WHO), “Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes”. It is avoidable and can be cured. In 2020, almost half of the world's population was at the peril of malaria. Nearly all cases and demises happen in sub-Saharan Africa. There were approximately 241 million cases of malaria in 2020 and the supposed number of malaria demises was 627,000. Children aged under 5 years are the most susceptible class troubled by malaria. The increasing predominance of Malaria is therefore driving the growth of the Global Mefloquine Industry, thereby contributing to the Global Mefloquine Industry Outlook during the forecast period 2022-2027.
Mefloquine Market Challenges
Side Effects of Mefloquine are Hampering the Growth of the Mefloquine Market:
Mefloquine's brand name involves Lariam. Halofantrine or ketoconazole should not be consumed while consuming mefloquine and for at least 15 weeks subsequent to halting its intake. Severe, life-alarming side effects on the heart can happen if one consumes halofantrine prior to mefloquine being emptied from the body. Consumption of chloroquine, quinine or quinidine needs to be avoided while one is consuming mefloquine. Mefloquine's side effects may harm the thinking or reactions. One needs to be cautious of Mefloquine's side effects if one does anything that requires one to be conscious. These issues are thus hampering the growth of the Global Mefloquine Market.
Mefloquine Industry Outlook
Novel product launches, expansions, agreements, joint ventures and partnerships are key strategies adopted by players in the Global Mefloquine Market. The top 10 companies in the Global Mefloquine market are:
- Toronto Research Chemicals
- Alfa Chemistry
- Waterstone Technology
- 2A PharmaChem
- 3B Scientific
- Chembest Research Laboratories
- Ningbo Taikang Chemical
- Hangzhou J&H Chemical
- Ningbo Taikang Chemical
- Zydus Cadila
Recent Developments
- In March 2022, Alfa Chemistry declared the introduction of an extensive array of fluoro surfactants. This includes amphoteric surfactants, anionic surfactants, cationic surfactants, non-ionic surfactants, natural surfactants and more. Fluorosurfactants are constituted of polar hydrophilic heads and greatly hydrophobic fluorocarbon tails.
- In November 2021, Alfa Chemistry Testing Lab declared to offer one-stop fertilizer analysis testing solutions for manufacturers, suppliers, retailers and farmers globally. Almost all types of fertilizers can be examined and tested in Alfa Chemistry’s testing laboratories. Alfa Chemistry Testing Lab demonstrates superior possibilities with additional agricultural products & crop testing items like grain testing.
- In January 2020, 3B Scientific, endorsed an agreement to gain iSimulate for a confidential amount. 3B Scientific produces anatomical models. iSimulate offers clinical education technology and medical simulation solutions.
Relevant Reports:
Report Code: CMR 42697
Report Code: CMR 89229
Report Code: CMR 38041
For more Lifesciences and Healthcare Market reports, please click here
1. Mefloquine Market Overview
1.1 Definitions and Scope
2. Mefloquine Market - Executive Summary
3. Mefloquine Market – Market Landscape
3.1 Company Benchmarking - Key Companies
3.2 Key Company Financial Analysis
3.3 Market Share Analysis
3.4 Patent Analysis
3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Mefloquine Market – Startup Company Scenario (Premium)
4.1 Investment
4.2 Revenue
4.3 Venture Capital and Funding Scenario
5. Mefloquine Market – Industry Market Entry Scenario Premium (Premium)
5.1 Regulatory Scenario
5.2 New Business and Ease of Doing business index
5.3 Case Studies of Successful Ventures
6. Mefloquine Market - Market Forces
6.1 Market Drivers
6.2 Market Constraints
6.3 Porter's five force model
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7. Mefloquine Market – Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle Analysis
8. Mefloquine Market – by Type (Market Size – $Million/$Billion)
8.1 Purity 98%
8.2 Purity 99%
8.3 Others
9. Mefloquine Market – by End-use Industry (Market Size – $Million/$Billion)
9.1 Chemical Industry
9.2 Pharmaceutical Industry
10. Mefloquine Market - by Geography (Market Size - $Million/Billion)
10.1 North America
10.1.1 the U.S.
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 the UK
10.2.4 Italy
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Asia-Pacific
10.3.1 China
10.3.2 Japan
10.3.3 South Korea
10.3.4 India
10.3.5 Australia & New Zealand
10.3.6 Rest of Asia-Pacific
10.4 South America
10.4.1 Brazil
10.4.2 Argentina
10.4.3 Chile
10.4.4 Colombia
10.4.5 Rest of South America
10.5 Rest Of The World
10.5.1 the Middle East
10.5.2 Africa
11. Mefloquine Market - Market Entropy
11.1 New product launches
11.2 M&A's, collaborations, JVs and partnerships
12. Mefloquine Market – Industry Competition Landscape (Premium)
12.1 Market Share Analysis
12.1.1 Market Share by Region – Key Companies
12.1.2 Market Share by Countries – Key Companies
12.2 Competition Matrix
12.3 Best Practices for Companies
13. Mefloquine Market – Key Company List by Country Premium (Premium)
14. Mefloquine Market - Company Analysis
14.1 Company 1
14.2 Company 2
14.3 Company 3
14.4 Company 4
14.5 Company 5
14.6 Company 6
14.7 Company 7
14.8 Company 8
14.9 Company 9
14.10 Company 10
* "Financials would be provided to private companies on a best-effort basis."
Connect with our experts to get customized reports that best suit your requirements. Our reports include global-level data, niche markets and competitive landscape.
LIST OF TABLES
1.Global Mefloquine Market, by Type Market 2023-2030 ($M)2.Global Mefloquine Market Analysis and Forecast by Type and Application Market 2023-2030 ($M)
3.Global Mefloquine Market, by Type Market 2023-2030 (Volume/Units)
4.Global Mefloquine Market Analysis and Forecast by Type and Application Market 2023-2030 (Volume/Units)
5.North America Mefloquine Market, by Type Market 2023-2030 ($M)
6.North America Mefloquine Market Analysis and Forecast by Type and Application Market 2023-2030 ($M)
7.South America Mefloquine Market, by Type Market 2023-2030 ($M)
8.South America Mefloquine Market Analysis and Forecast by Type and Application Market 2023-2030 ($M)
9.Europe Mefloquine Market, by Type Market 2023-2030 ($M)
10.Europe Mefloquine Market Analysis and Forecast by Type and Application Market 2023-2030 ($M)
11.APAC Mefloquine Market, by Type Market 2023-2030 ($M)
12.APAC Mefloquine Market Analysis and Forecast by Type and Application Market 2023-2030 ($M)
13.MENA Mefloquine Market, by Type Market 2023-2030 ($M)
14.MENA Mefloquine Market Analysis and Forecast by Type and Application Market 2023-2030 ($M)
LIST OF FIGURES
1.US Global Mefloquine Market Revenue, 2023-2030 ($M)2.Canada Global Mefloquine Market Revenue, 2023-2030 ($M)
3.Mexico Global Mefloquine Market Revenue, 2023-2030 ($M)
4.Brazil Global Mefloquine Market Revenue, 2023-2030 ($M)
5.Argentina Global Mefloquine Market Revenue, 2023-2030 ($M)
6.Peru Global Mefloquine Market Revenue, 2023-2030 ($M)
7.Colombia Global Mefloquine Market Revenue, 2023-2030 ($M)
8.Chile Global Mefloquine Market Revenue, 2023-2030 ($M)
9.Rest of South America Global Mefloquine Market Revenue, 2023-2030 ($M)
10.UK Global Mefloquine Market Revenue, 2023-2030 ($M)
11.Germany Global Mefloquine Market Revenue, 2023-2030 ($M)
12.France Global Mefloquine Market Revenue, 2023-2030 ($M)
13.Italy Global Mefloquine Market Revenue, 2023-2030 ($M)
14.Spain Global Mefloquine Market Revenue, 2023-2030 ($M)
15.Rest of Europe Global Mefloquine Market Revenue, 2023-2030 ($M)
16.China Global Mefloquine Market Revenue, 2023-2030 ($M)
17.India Global Mefloquine Market Revenue, 2023-2030 ($M)
18.Japan Global Mefloquine Market Revenue, 2023-2030 ($M)
19.South Korea Global Mefloquine Market Revenue, 2023-2030 ($M)
20.South Africa Global Mefloquine Market Revenue, 2023-2030 ($M)
21.North America Global Mefloquine By Application
22.South America Global Mefloquine By Application
23.Europe Global Mefloquine By Application
24.APAC Global Mefloquine By Application
25.MENA Global Mefloquine By Application